Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Opioid Optimization of Dosing and Selections (GOODS) Study

NCT03579121 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03579121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03579121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Opioid Optimization of Dosing and Selections (GOODS) Study
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
October 12, 2018
Completion date
April 1, 2022
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perioperative/postoperative complications